Viral Load Dynamics in Plasma and Semen When Antiretroviral Therapy Is Initiated During Early HIV-1 Infection

被引:1
|
作者
Gilada, Trupti [1 ,2 ]
Ulrich, Angela K. [2 ,3 ]
Wang, Yixin [4 ]
Lama, Javier R. [5 ]
Alfaro, Ricardo [6 ]
Harb, Socorro
Daza, Glenda [7 ]
Holte, Sarah [8 ,9 ,10 ]
Pasalar, Siavash [4 ]
Rios, Jessica [11 ]
Ganoza, Carmela [12 ]
Dasgupta, Sayan [4 ]
Coombs, Robert W.
Duerr, Ann [4 ,8 ,9 ,13 ]
机构
[1] Unison Medicare & Res Ctr, Mumbai, India
[2] Univ Minnesota, Ctr Infect Dis Res & Policy, Minneapolis, MN USA
[3] Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN USA
[4] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, Seattle, WA USA
[5] Asociac Civil Impacta Salud & Educ, Lima, Peru
[6] Ctr Invest Tecnol Biomed & Medioambientales, Lima, Peru
[7] Univ Washington, Sch Med, Seattle, WA USA
[8] Fred Hutchinson Canc Ctr, Publ Hlth Sci Div, Seattle, WA USA
[9] Univ Washington, Dept Global Hlth, Seattle, WA USA
[10] Univ Washington, Dept Biostat, Seattle, WA USA
[11] Pharmaceut Prod Dev Inc, Lima, Peru
[12] HIV Vaccine Trials Network, Lima, Peru
[13] Fred Hutchinson Canc Ctr, Vaccine & Infect Dis Div, 1100 Fairview Ave N, Mailstop M1-C108, Seattle, WA 98109 USA
基金
美国国家卫生研究院;
关键词
HIV; viral load; antiretroviral therapy (ART); plasma; seminal plasma; blood; semen; SEMINAL PLASMA; DEPTH; UNCERTAINTY; VALIDATION; KINETICS; BLOOD;
D O I
10.1093/infdis/jiad520
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We assessed human immunodeficiency virus (HIV) load in plasma and semen during primary HIV infection using serial samples of semen and plasma during the first 24 weeks after diagnosis in untreated participants and those who started antiretroviral therapy (ART) immediately at diagnosis. In the absence of treatment, semen viral load was >1000 copies/mL in almost all specimens (83%) collected 2-10 weeks after the estimated date of HIV acquisition and remained >1000 copies/mL in 35% of untreated participants at the last observed time point. Thus, in the absence of ART, semen viral load remained at a level consistent with transmissibility throughout primary infection.
引用
收藏
页码:1141 / 1146
页数:6
相关论文
共 50 条
  • [41] Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy
    Ruggiero, Alessandra
    Cozzi-Lepri, Alessandro
    Beloukas, Apostolos
    Richman, Douglas
    Khoo, Saye
    Phillips, Andrew
    Geretti, Anna Maria
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (02):
  • [42] Combined antiretroviral therapy is effective on blood plasma HIV-1-RNA: what about semen HIV-1-RNA levels?
    Ghosn, Jade
    Chaix, Marie-Laure
    AIDS, 2010, 24 (02) : 309 - 311
  • [43] Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load
    Cu-Uvin, Susan
    DeLong, Allison K.
    Venkatesh, Kartik K.
    Hogan, Joseph W.
    Ingersoll, Jessica
    Kurpewski, Jaclynn
    De Pasquale, Maria Pia
    D'Aquila, Richard
    Caliendo, Angela M.
    AIDS, 2010, 24 (16) : 2486 - 2494
  • [44] Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen
    Gilliam, BL
    Dyer, JR
    Fiscus, SA
    Marcus, C
    Zhou, S
    Wathen, L
    Freimuth, WW
    Cohen, MS
    Eron, JJ
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 15 (01) : 54 - 60
  • [45] HIV sequence diversity during the early phase of infection is associated with HIV DNA reductions during antiretroviral therapy
    Wang, Nidan
    Li, Yijia
    Han, Yang
    Xie, Jing
    Li, Taisheng
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (06) : 982 - 988
  • [46] Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
    May, Margaret T.
    Gompels, Mark
    Delpech, Valerie
    Porter, Kholoud
    Orkin, Chloe
    Kegg, Stephen
    Hay, Phillip
    Johnson, Margaret
    Palfreeman, Adrian
    Gilson, Richard
    Chadwick, David
    Martin, Fabiola
    Hill, Teresa
    Walsh, John
    Post, Frank
    Fisher, Martin
    Ainsworth, Jonathan
    Jose, Sophie
    Leen, Clifford
    Nelson, Mark
    Anderson, Jane
    Sabin, Caroline
    AIDS, 2014, 28 (08) : 1193 - 1202
  • [47] Predictive value of HIV-1 viral load on risk for opportunistic infection
    Swindells, S
    Evans, S
    Zackin, R
    Goldman, M
    Haubrich, R
    Filler, SG
    Balfour, HH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (02) : 154 - 158
  • [48] HIV-1 Coreceptor Usage in Paired Plasma RNA and Proviral DNA from Patients With Acute and Chronic Infection Never Treated With Antiretroviral Therapy
    Bon, I.
    Turriziani, O.
    Musumeci, G.
    Clo, A.
    Montagna, C.
    Morini, S.
    Calza, L.
    Gibellini, D.
    Antonelli, G.
    Re, M. C.
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (02) : 315 - 322
  • [49] Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection
    Gay, Cynthia L.
    Mayo, Ashley J.
    Mfalila, Chelu K.
    Chu, Haitao
    Barry, Anna C.
    Kuruc, Joann D.
    Mcgee, Kara S.
    Kerkau, Melissa
    Sebastian, Joe
    Fiscus, Susan A.
    Margolis, David M.
    Hicks, Charles B.
    Ferrari, Guido
    Eron, Joseph J.
    AIDS, 2011, 25 (07) : 941 - 949
  • [50] Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load
    Baggaley, Rebecca F.
    Griffin, Jamie T.
    Chapman, Ruth
    Hollingsworth, T. Deirdre
    Nagot, Nicolas
    Delany, Sinead
    Mayaud, Philippe
    de Wolf, Frank
    Fraser, Christophe
    Ghani, Azra C.
    Weiss, Helen A.
    AIDS, 2009, 23 (08) : 1005 - 1013